Cure Sickle Cell

治愈镰状细胞（CureSC）倡议由国家心脏，肺和血液研究所（NIH/NHLBI）于2017年创建，旨在： · 积极动员镰状细胞病患者、家庭成员、护理人员和倡导者共同努力，寻求治愈之路。 · 利用安全可靠的基因疗法，扩大改善镰状细胞病患者生活的机会 · 利用政府机构、生物制药公司和研究人员之间的公私伙伴关系和合作，更快地推进新的和创新的治疗和技术

The Cure Sickle Cell (CureSC) Initiative was created in 2017 by the National Heart, Lung, and Blood Institute (NIH/NHLBI) to: • Actively engage the sickle cell disease community of patients, family members, caregivers and advocates to work together on a path to the cure • Utilize the emergence of safe reliable genetic therapies that broadens opportunities to improve the lives of individuals with sickle cell disease • Use public-private partnership and collaboration among government agencies, biopharmaceutical companies and researchers to result in more rapid advancement of new and innovative treatments and technologies